AlzChem Group AG Announces 10th Interim Report on Share Buyback Program

On June 16, 2025, AlzChem Group AG disclosed its 10th interim report concerning its share buyback program, as mandated by Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052. The company, headquartered in Trostberg, Germany, specializes in the production of chemical products, including nutritional feeds, dietary supplements, and guanidine hydrochloride salts for various sectors such as biotechnology, diagnostics, and pharmacy. Additionally, AlzChem provides silicon nitride powder for ceramics, coatings, and photovoltaic applications.

During the period from June 9 to June 13, 2025, AlzChem Group AG acquired a total of 692 shares as part of its ongoing share buyback program, which was initially announced on November 29, 2024. This acquisition was executed by a financial institution on behalf of AlzChem through the XETRA stock exchange. As of this interim report, the total number of shares repurchased under the program amounts to 71,260.

The share buyback initiative is part of AlzChem’s strategic efforts to enhance shareholder value. The company’s shares are listed on the XETRA exchange, and as of June 12, 2025, the close price was EUR 130. The company’s market capitalization stands at EUR 2.55 billion, with a price-to-earnings ratio of 23.06. Over the past year, AlzChem’s share price has seen significant fluctuations, reaching a 52-week high of EUR 134.8 on June 5, 2025, and a 52-week low of EUR 40.4 on September 18, 2024.

In the broader market context, the SDAX, which includes AlzChem as a member, showed a slight decline at the end of the trading week on June 13, 2025. The index closed at 16,712.79 points, down 1.15% from the previous day. Since the beginning of the year, the SDAX has experienced a 20.35% increase, reflecting a generally positive trend in the market.

AlzChem Group AG remains committed to its strategic initiatives, including the share buyback program, to strengthen its market position and deliver value to its shareholders. The company continues to focus on its core business areas, leveraging its expertise in chemical production to meet the demands of its diverse customer base.